Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 3/20 | 0.66 |
| ▸ | TK2 | O00142 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.58 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL933039 | 1.00 | TK1 (0.66) | TK1TK2LMNASMN1; SMN2ALOX12 | |
| Phosphoric Acid SCHEMBL8600183 | 0.96 | TK1 (0.61) | TK1TK2LMNASMN1; SMN2ALOX12 | |
| SCHEMBL21585108 | 0.94 | TK1 (0.63) | TK1TK2LMNASMN1; SMN2ALOX12 | |
| SCHEMBL3931463 | 0.94 | TK1 (0.63) | TK1TK2LMNASMN1; SMN2ALOX12 | |
| SCHEMBL3931456 | 0.94 | TK1 (0.63) | TK1TK2LMNASMN1; SMN2ALOX12 | |
| SCHEMBL7166566 | 0.93 | TK1 (0.62) | TK1TK2LMNASMN1; SMN2ALOX12 | |
| SCHEMBL7166563 | 0.93 | TK1 (0.62) | TK1TK2LMNASMN1; SMN2ALOX12 | |
| SCHEMBL4263815 | 0.92 | TK1 (0.61) | TK1TK2LMNASMN1; SMN2ALOX12 | |
| SCHEMBL7172039 | 0.92 | TK1 (0.61) | TK1TK2LMNASMN1; SMN2ALOX12 | |
| SCHEMBL7170550 | 0.92 | TK1 (0.61) | TK1TK2LMNASMN1; SMN2ALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3149167-B1 | APTAMER TARGETING MAGE-A3 PEPTIDE AND USES THEREOF | ACADEMIA SINICA (TW) | 2019-09-04 | — | — | EP | claimed |
| US-9976146-B2 | Aptamer targeting MAGE-A3 peptide and uses thereof | IANALYZER INCORPORATION (TW) | 2018-05-22 | — | — | US | claimed |
| US-20170183660-A1 | APTAMER TARGETING MAGE-A3 PEPTIDE AND USES THEREOF | ACADEMIA SINICA (TW) | 2017-06-29 | — | — | US | claimed |
| EP-3149167-A1 | APTAMER TARGETING MAGE-A3 PEPTIDE AND USES THEREOF | Academia Sinica (TW) | 2017-04-05 | — | — | EP | claimed |
| WO-2015184224-A1 | APTAMER TARGETING MAGE-A3 PEPTIDE AND USES THEREOF | ACADEMIA SINICA (TW) | 2015-12-03 | — | — | WO | claimed |
| US-12098370-B2 | Method for generating aptamers with improved off-rates | SOMALOGIC OPERATING CO., INC. (US) | 2024-09-24 | — | — | US | disclosed |
| CN-118064441-A | Methods of producing aptamers with improved dissociation rates | 私募蛋白质体运营有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-109415723-B | Improved promoters and compositions | 牛津大学创新有限公司 | 2024-04-19 | — | — | CN | disclosed |
| US-20220090080-A1 | Method for Generating Aptamers with Improved Off-Rates | SOMALOGIC, INC. (US) | 2022-03-24 | — | — | US | disclosed |
| US-11111495-B2 | Method for generating aptamers with improved off-rates | SOMALOGIC, INC. (US) | 2021-09-07 | — | — | US | disclosed |
| US-20190330634-A1 | Method for Generating Aptamers with Improved Off-Rates | SOMALOGIC OPERATING CO., INC. | 2019-10-31 | — | — | US | disclosed |
| EP-3149167-B1 | APTAMER TARGETING MAGE-A3 PEPTIDE AND USES THEREOF | ACADEMIA SINICA (TW) | 2019-09-04 | — | — | EP | disclosed |
| US-5763208-A | Oligonucleotides and their analogs capable of passive cell membrane permeation | GILEAD SCIENCES, INC. (US) | 1998-06-09 | — | — | US | disclosed |
| US-5756291-A | IDENTIFYING OLIGOMER SEQUENCES; QUALITATIVE ANALYSIS; ANALYSIS OF THROMBIN BY COMPLEXING | GILEAD SCIENCES, INC. (US) | 1998-05-26 | — | — | US | disclosed |
| WO-1998016661-A2 | MORPHATIDES: NOVEL SHAPE AND STRUCTURE LIBRARIES | MORPHAGEN (US) | 1998-04-23 | — | — | WO | disclosed |
| WO-1998004575-A2 | LIPOPHILIC OLIGONUCLEOTIDE ANALOGS | GILEAD SCIENCES, INC. (US) | 1998-02-05 | — | — | WO | disclosed |
| US-5633360-A | CONTAINS AT LEAST TWO NUCLEOSIDE RESIDUES AND INTERNUCLEOTIDE LINKAGES | GILEAD SCIENCES, INC. (US) | 1997-05-27 | — | — | US | disclosed |
| EP-0572529-A1 | APTAMER SPECIFIC FOR BIOMOLECULES AND METHOD OF MAKING | GILEAD SCIENCES, INC. (US) | 1993-12-08 | — | — | EP | disclosed |
| WO-1992014842-A1 | APTAMERS SPECIFIC FOR THROMBIN AND METHODS OF USE | GILEAD SCIENCES, INC. (US) | 1992-09-03 | — | — | WO | disclosed |
| WO-1992014843-A1 | APTAMER SPECIFIC FOR BIOMOLECULES AND METHOD OF MAKING | GILEAD SCIENCES, INC. (US) | 1992-09-03 | — | — | WO | disclosed |